U.S., April 16 -- ClinicalTrials.gov registry received information related to the study (NCT07532421) titled 'Probiotic Intervention on the Development of Allergic Diseases in Infants Exposed to Antibiotics Early in Life' on April 08.
Brief Summary: Early antibiotic exposure is an important environmental factor that disrupts the establishment of the infant gut microbiota and leads to microbial dysbiosis. Accumulating epidemiological evidence indicates that exposure to antibiotics early in life (including both prenatal and postnatal periods) is significantly associated with an increased risk of allergic diseases in childhood. As live microorganisms, probiotics hold potential as a preventive strategy against allergies due to their ability to...